Quantcast

Posts related to ‘Synavive’

Biotech Implosion: CombinatoRx (CRXX)

CombinatoRx, Incorporated (NASDAQ: CRXX) is seeing its stock implode this morning.  The company released data from its Phase IIb study of Synavive (CRx-102) for knee osteoarthritis showing that its Synavive ...
Read Full Story »